Cargando…
Theranostic Designed Near-Infrared Fluorescent Poly (Lactic-co-Glycolic Acid) Nanoparticles and Preliminary Studies with Functionalized VEGF-Nanoparticles
Poly-lactic-co-glycolic acid nanoparticles (PLGA-NPs) were approved by the Food and Drug Administration (FDA) for drug delivery in cancer. The enhanced permeability and retention (EPR) effect drives their accumulation minimizing the side effects of chemotherapeutics. Our aim was to develop a new the...
Autores principales: | Varani, Michela, Galli, Filippo, Capriotti, Gabriela, Mattei, Maurizio, Cicconi, Rosella, Campagna, Giuseppe, Panzuto, Francesco, Signore, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355639/ https://www.ncbi.nlm.nih.gov/pubmed/32516917 http://dx.doi.org/10.3390/jcm9061750 |
Ejemplares similares
-
Synthesis and Biodistribution of (99m)Tc-Labeled PLGA Nanoparticles by Microfluidic Technique
por: Varani, Michela, et al.
Publicado: (2021) -
Extensive Histopathological Characterization of Inflamed Bowel in the Dextran Sulfate Sodium Mouse Model with Emphasis on Clinically Relevant Biomarkers and Targets for Drug Development
por: Bonfiglio, Rita, et al.
Publicado: (2021) -
Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics
por: Min, Hyun Su, et al.
Publicado: (2015) -
Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor
por: Yang, Xiaoye, et al.
Publicado: (2018) -
Novel Fluorinated Poly (Lactic-Co-Glycolic acid) (PLGA) and Polyethylene Glycol (PEG) Nanoparticles for Monitoring and Imaging in Osteoarthritis
por: Zerrillo, Luana, et al.
Publicado: (2021)